In recent years, Selendy & Gay partners have served as national or lead trial counsel in some of the most cutting-edge products liability initiatives around the country involving consumer, medical device, and pharmaceutical companies.
High-stakes products litigation is almost always enterprise-threatening and resource-intensive. It can require simultaneous representation of our clients in parallel civil, regulatory, and criminal arenas: for example, in multi-district and class action litigation, individual personal injury claims, internal preventative assessments and pro-active audits, consumer fraud investigations by state attorneys general, False Claims Act, and qui tam actions.
By joining knowledge of our clients’ needs and objectives with our deep experience with prosecutors, regulators, and in courtrooms around the country, we have worked efficiently across these complex and competing arenas to produce game-changing, and, in some instances, save-the-company results for a number of nationally known clients.
Our partners’ representative engagements include:
- Regeneron Pharmaceuticals, a leading biotech company, in a contract dispute with its joint venture partner relating to liability for the costs for clinical trials conducted for a product that is the subject of the joint venture.
- A dermatologic pharmaceuticals company, in providing advice regarding potential arbitration following the sale of a patent of a topical skin treatment and the subsequent breach of the duty to reasonably market and commercialize the product.
- A Fortune 500 consumer products company, in defending and obtaining a key appellate ruling from an en banc panel of the Fourth Circuit that federal judges may vacate otherwise unappealable remand orders where there is evidence of attorney fraud associated with the remand.
- An international beauty products company, in advising on potential litigation resulting from a contractual dispute with an advertising agency.